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simplex infection: a case study
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Shimeru Kamihira4 and Atsushi Utani1*Abstract
We report the development and treatment of eczema herpeticum in a 51-year-old male suffering from adult T-cell
leukemia (ATL). Lesions of eczema herpeticum coexisted with the skin lesions of ATL. Treatment of eczema
herpeticum resulted in a concomitant improvement in the symptoms of ATL, including a reduction in the size of
the ATL plaques, for over 2 months before relapse.
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Eczema herpeticum is an uncommon viral infection
caused by the herpes simplex virus (HSV). It affects
patients with a pre-existing primary dermatological con-
dition, such as atopic dermatitis, psoriasis, mycosis fun-
goides, and/or burns [1]. Although HSV infections occur
frequently in adult T-cell leukemia (ATL) patients, ec-
zema herpeticum at ATL skin lesions has never been
reported before in the literature. In this Case Report, we
describe the occurrence and treatment of eczema herpe-
ticum in a patient suffering from ATL.Case presentation
A 51-year-old Japanese male with an 11-year history of
ATL presented with erythematous plaques all over his
torso (Figure 1a). A test for serum anti-human T-cell
leukemia virus type 1 (HTLV-1) antibody was positive.
Histological examination of a biopsy specimen taken
from an infiltrated erythema on the chest showed clus-
tered atypical lymphocytes at dermo-epithelial junction,
also known as Pautrier’s microabscesses, and infiltration
of atypical cells in the upper dermis (Figure 2a and b).
Simultaneously, southern blot analysis of DNA from an
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reproduction in any medium, provided the orin the lane containing the EcoRI-digested sample
(Figure 3; see arrow), although there was no signal in the
lane containing the PstI-digested sample, probably due
to the low amount of sample (Figure 3). These results
indicate monoclonal integration of proviral HTLV-1 in
the skin lesion. Laboratory examinations revealed nor-
mal levels of serum calcium, normal levels of lactate de-
hydrogenase (LDH), and no abnormal cells. A computed
tomography (CT) scan showed an absence of visceral in-
volvement, including no lymph node swelling. The pa-
tient was therefore diagnosed with indolent ATL. He
had been undergoing treatment with a combination of
psoralen-ultraviolet A therapy, narrow-band ultraviolet B
radiation, and topical steroid ointment for 10 years at
our hospital. However, the lesions had gradually
increased and become enlarged over this period.
Small vesicles, crusts, erosion, and infiltrated itchy
erythemas suddenly developed in the almost every pre-
existing ATL skin lesions on the entire trunk
(Figure 1b). Examination of a biopsy specimen revealed
acantholysis and ballooning degeneration of epidermal
keratinocytes in the vesicles (Figure 2c and d). These
degenerated epidermal cells were positive for an anti-
HSV antibody that recognized both HSV-1 and HSV-2
(Figure 2e). In addition, Pautrier’s microabscesses were
observed adjacent to the erosion in the biopsied sample
(Figure 2c). An enzyme immunoassay revealed levels of
serum immunoglobulin G and M antibodies againstLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Clinical pictures of the anterior trunk. Timings of the clinical pictures are depicted in figure 4. (a) ATL skin lesions on the chest
2 months before the onset of HSV infection. (b) Small vesicles, crusts, and erosion developing on the pre-existing ATL skin lesions. (c) Complete
disappearance of the ATL skin lesions as well as eczema herpeticum improving in parallel 14 days after treatment.
Figure 2 Histopathological examinations. Time course of the
biopsies is shown in figure 4. (a) (b) Biopsy from erythema on the
chest showed clustering atypical lymphocytes at the dermo-
epithelial junction, also known as Pautrier’s microabscesses and a
moderate infiltration of atypical cells in the upper dermis.
(hematoxylin and eosin (H&E) stain, original magnification (a): ×100;
(b): ×400). (c) Biopsy of the vesicles demonstrated erosion with the
degenerated epidermis and concomitantly clustering atypical
lymphocytes, Pautrier’s microabscesses (arrows) (H&E stain, original
magnification × 40). (d) Magnified view of the square in (c) revealed
acantholytic and swollen cells (arrows) with neutrophil (H&E stain,
original magnification × 400). (e) HSV in epidermal cells at vesicles
(Immunohistochemical staining with anti-HSV antibody, original
magnification × 400).
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range <0.8), respectively. These results indicated a recur-
rent HSV infection that was strictly limited to the pre-
existing ATL skin lesions.
Acyclovir was administered intravenously in a daily dose
of 750 mg for 7 days. Within 7 days, re-epithelialization of
the erosion was achieved, and the ATL skin lesions and
eczema herpeticum improved concomitantly (Figure 1c).
The clinical response of the ATL lesions to the anti-
herpes treatment persisted for more than 2 months;
however, relapse then occurred, with lesions gradually
reappearing at locations that were different from thoseFigure 3 Southern blot analysis of DNA from the ATL skin
lesion on the anterior chest. Lane M: molecular weight marker,
lane 1, samples of HTLV-1 monoclonal integration; 2, samples from
normal volunteer; 3, samples from the patient’s skin lesion. E, EcoR1-
digested sample; P, PstI-digested sample. The arrow indicates a
monoclonal HTLV-1 proviral integration.
Figure 4 Time course of clinical events and examinations.
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and examinations in this case is depicted in Figure 4.
Discussion
Development of eczema herpeticum appears to be linked
to defects in cellular immunity and disruption of the
skin barrier. A report suggested that the number of
regulatory T (Treg) cells increases in ATL patients [2].
Treg cells hamper the development of immunity against
viral infections, such as HSV [3,4]. In addition, HTLV-1
activates cellular genes, including the cytokine gene IL-4
[5]. High levels of IL-4 allow the development of eczema
herpeticum by suppressing the expression of cathelicidin
peptide LL-37, which exhibits activity against HSV [6]. It
is also noteworthy that IL-17 mRNA is highly expressed
in HTLV-1-infected T-cells [7] and that IL-17-mediated
inhibition of natural killer cell activity induces eczema
vaccinatum in mice [8]. Together with disruption of the
skin barrier in the ATL lesions, UV-irradiation and to-
pical steroid treatment may also participate in HSV in-
fection. Furthermore, increased Treg cells and high
levels of IL-4 and/or IL-17 associated with ATL infection
may lead skin conditions vulnerable to HSV infection.
A study has shown that adenovirus vaccine injection
into the tumoral lesions of cutaneous T-cell lymphoma
leads to tumor reduction by the induction of interferon
gamma, a subtype 1 helper T (Th1) cell cytokine [9]. In
the present case, the Th1-dominant immune response
for anti-viral immunity [10] may have been activated fol-
lowing HSV infection, whereupon it contributed to the
attenuation of the ATL skin lesions.
Conclusions
HSV infection affected our patient only within the con-
fines of pre-existing ATL skin lesions on his torso.
Interestingly, these ATL skin lesions improved in parallel
with the symptoms of HSV infection upon treatment
with acyclovir. This uncommon phenomenon observed
in the present case may shed a light to a development of
novel strategies for treatment of ATL.
Consent
Written informed consent was obtained from the patient
for publication of this Case Report and any accompanyingimages. A copy of the written consent is available for re-
view by the Editor-in-Chief of this journal.
Abbreviations
ATL: Adult T-cell leukemia; CT: Computed tomography; H&E: Hematoxylin
and eosin; HSV: Herpes simplex virus; HTLV-1: Human T-cell leukemia virus
type 1; LDH: Lactate dehydrogenase; Th1: Subtype 1 helper T;
Treg: Regulatory T.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
HT wrote and edited the manuscript. HT, FK, and FT carried out collection of
patient data and patient monitoring through the whole period of follow up.
FO and AT edited the manuscript. SY and SK participated in the study design
and coordination and helped to draft the manuscript. All authors read and
approved the final manuscript.
Author details
1Department of Dermatology, Nagasaki University Graduate School of
Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan.
2Department of Dermatology, Japanese Red Cross Nagasaki Genbaku
Hospital, Nagasaki, Japan. 3Department of Dermatology, Kurume University
School of Medicine, Kurume, Japan. 4Department of Laboratory Medicine,
Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Received: 3 April 2012 Accepted: 26 September 2012
Published: 1 October 2012
References
1. Santmyire-Rosenberger BR, Nigra TP: Psoriasis herpeticum: three cases of
Kaposi’s varicelliform eruption in psoriasis. J. Am. Acad. Dermatol. 2005,
53:52–56.
2. Toulza F, Heaps A, Tanaka Y, Taylor GP, Bangham CR: High frequency of
CD4 + FoxP3+ cells in HTLV-1 infection: inverse correlation with HTLV-1-
specific CTL response. Blood 2008, 111:5047–5053.
3. Rouse BT, Suvas S: Regulatory cells and infectious agents: detentes
cordiale and contraire. J Immunol 2004, 173:2211–2215.
4. Fernandez MA, Puttur FK, Wang YM, Howden W, Alexander SI, Jones CA: T
regulatory cells contribute to the attenuated primary CD8+ and CD4+ T
cell responses to herpes simplex virus type 2 in neonatal mice.
J Immunol 2008, 180:1556–1564.
5. Li-Weber M, Giaisi M, Chlichlia K, Khazaie K, Krammer PH: Human T cell
leukemia virus type I Tax enhances IL-4 gene expression in T cells. Eur J
Immunol 2001, 31:2623–2632.
6. Howell MD, Wollenberg A, Gallo RL, Flaig M, Streib JE, Wong C, Pavicic T,
Boguniewicz M, Leung DY: Cathelicidin deficiency predisposes to eczema
herpeticum. J Allergy Clin Immunol 2006, 117:836–841.
7. Dodon MD, Li Z, Hamaia S, Gazzolo L: Tax protein of human T-cell
leukaemia virus type 1 induces interleukin 17 gene expression in T cells.
J Gen Virol 2004, 85:1921–1932.
8. Kawakami Y, Tomimori Y, Yumoto K, Hasegawa S, Ando T, Tagaya Y, Crotty S,
Kawakami T: Inhibition of NK cell activity by IL-17 allows vaccinia virus to
induce severe skin lesions in a mouse model of eczema vaccinatum.
J Exp Med 2009, 206:1219–1225.
Tomita et al. Virology Journal 2012, 9:224 Page 4 of 4
http://www.virologyj.com/content/9/1/2249. Whittaker SJ, Foss FM: Efficacy and tolerability of currently available
therapies for the mycosis fungoides and Sezary syndrome variants of
cutaneous T-cell lymphoma. Cancer Treat Rev 2007, 33:146–160.
10. Suryawanshi A, Veiga-Parga T, Rajasagi NK, Reddy PB, Sehrawat S, Sharma S,
Rouse BT: Role of IL-17 and Th17 cells in herpes simplex virus-induced
corneal immunopathology. J Immunol 2011, 187:1919–30.
doi:10.1186/1743-422X-9-224
Cite this article as: Tomita et al.: Attenuation of an adult T-cell leukemia
skin lesion after treatment of a concomitant herpes simplex infection: a
case study. Virology Journal 2012 9:224.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
